Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters William R. Strohl Review Article Open access 16 July 2015 Pages: 215 - 239
Comparative Immunogenicity of TNF Inhibitors: Impact on Clinical Efficacy and Tolerability in the Management of Autoimmune Diseases. A Systematic Review and Meta-Analysis Sarah S. ThomasNabeel BorazanDaniel E. Furst Systematic Review 18 August 2015 Pages: 241 - 258
Cost Effectiveness of Monoclonal Antibody Therapy for Rare Diseases: A Systematic Review Taehwan ParkScott K. GriggsDong-Churl Suh Systematic Review 12 August 2015 Pages: 259 - 274
How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009–2013 Ylenia IngrasciottaFrancesco GiorgianniGianluca Trifirò Original Research Article Open access 14 July 2015 Pages: 275 - 284
An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin Alessandra GianoncelliSara A. BoniniMaurizio Memo Original Research Article Open access 03 September 2015 Pages: 285 - 300